MACQUARIE GROUP LTD - ADAMAS PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of ADAMAS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$5,200,000
-36.7%
1,799,420
-17.0%
0.01%
-8.3%
Q4 2019$8,215,000
-29.0%
2,167,416
-4.1%
0.01%
-36.8%
Q3 2019$11,563,000
-74.2%
2,260,678
-68.8%
0.02%
-24.0%
Q2 2019$44,865,000
+140.7%
7,236,474
+176.0%
0.02%
-21.9%
Q1 2019$18,640,000
-19.4%
2,621,700
-3.2%
0.03%
-28.9%
Q4 2018$23,128,000
-35.3%
2,708,217
+51.7%
0.04%
-22.4%
Q3 2018$35,738,000
+5.6%
1,785,118
+36.2%
0.06%0.0%
Q2 2018$33,846,000
+21.6%
1,310,310
+12.5%
0.06%
+13.7%
Q1 2018$27,841,000
-7.8%
1,164,898
+30.7%
0.05%
-3.8%
Q4 2017$30,195,000
+89.9%
890,962
+18.6%
0.05%
+82.8%
Q3 2017$15,899,000751,0280.03%
Other shareholders
ADAMAS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 984,329$6,999,0004.03%
Broadfin Capital, LLC 2,469,894$17,561,0003.63%
Healthcare Value Capital, LLC 100,000$711,0002.74%
ARMISTICE CAPITAL, LLC 2,744,000$19,510,0001.07%
DELTEC ASSET MANAGEMENT LLC 536,836$3,817,0000.84%
SECTORAL ASSET MANAGEMENT INC 808,924$5,751,0000.69%
Mosaic Family Wealth, LLC 91,314$649,0000.26%
Worth Venture Partners, LLC 59,740$425,0000.24%
EMERALD ADVISERS, LLC 626,247$4,453,0000.18%
EMERALD MUTUAL FUND ADVISERS TRUST 565,319$4,019,0000.16%
View complete list of ADAMAS PHARMACEUTICALS INC shareholders